A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Flumazenil
Fenoterol
Fenoterol can cause a decrease in the absorption of Iobenguane resulting in a reduced serum concentration and potentially a decrease in efficacy.
Flumazenil
Alaproclate
Alaproclate may decrease effectiveness of Iobenguane as a diagnostic agent.
Flumazenil
Ritanserin
Ritanserin may decrease effectiveness of Iobenguane as a diagnostic agent.
Flumazenil
Indalpine
Indalpine may decrease effectiveness of Iobenguane as a diagnostic agent.
Flumazenil
Levomilnacipran
Levomilnacipran may decrease effectiveness of Iobenguane as a diagnostic agent.
Flumazenil
Seproxetine
Seproxetine may decrease effectiveness of Iobenguane as a diagnostic agent.
Flumazenil
Desvenlafaxine
Desvenlafaxine may decrease effectiveness of Iobenguane as a diagnostic agent.
Flumazenil
Milnacipran
Milnacipran may decrease effectiveness of Iobenguane as a diagnostic agent.
Flumazenil
Dapoxetine
Dapoxetine may decrease effectiveness of Iobenguane as a diagnostic agent.
Rifapentine
Vibegron
Fesoterodine may increase the smooth muscle relaxing activities of Vibegron.
Rifapentine
Satralizumab
The serum concentration of Fesoterodine can be decreased when it is combined with Satralizumab.
Rifapentine
Oliceridine
The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Fesoterodine is combined with Oliceridine.
Rifapentine
Abametapir
The serum concentration of Fesoterodine can be increased when it is combined with Abametapir.
Rifapentine
Tucatinib
The metabolism of Tucatinib can be decreased when combined with Fesoterodine.
Rifapentine
Cenobamate
The serum concentration of Fesoterodine can be decreased when it is combined with Cenobamate.
Rifapentine
Givosiran
The serum concentration of Fesoterodine can be increased when it is combined with Givosiran.
Rifapentine
Solriamfetol
The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Fesoterodine.
Rifapentine
Macimorelin
The therapeutic efficacy of Macimorelin can be decreased when used in combination with Fesoterodine.
Rifapentine
Nylidrin
The risk or severity of Tachycardia can be increased when Nylidrin is combined with Fesoterodine.
Rifapentine
Mefenorex
The risk or severity of Tachycardia can be increased when Fesoterodine is combined with Mefenorex.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3